Результаты поиска

Reimbursement of licensed cell and gene therapies across the major European healthcare markets.

ObjectiveThe aim of this research is to identify the pricing, reimbursement, and market access (P&R&MA) considerations most relevant to advanced therapy medicinal products (ATMPs) in the Big5EU, and to inform their manufacturers about the key drivers for securing adoption at a commercially viable reimbursed price.MethodologyThe research was structured following three main steps: 1) Identifying the market access pathways relevant to ATMPs through secondary research; 2) Validating the secondary research findings and addressing any data gaps in primary research, by qualitative interviews with nat

Совпадение в полном тексте источника
… The SMR is used by the Social Security Fund's health insurance (UNCAM) to set reimbursement rate, whereas the ASMR is taken into account by the pricing committee (CEPS) under the Ministry of Health, when negotiating the reimbursed ceiling price ( 9 ). …

The Danish health care system and epidemiological research: from health care contacts to database records.

Denmark has a large network of population-based medical databases, which routinely collect high-quality data as a by-product of health care provision. The Danish medical databases include administrative, health, and clinical quality databases. Understanding the full research potential of these data sources requires insight into the underlying health care system. This review describes key elements of the Danish health care system from planning and delivery to record generation. First, it presents the history of the health care system, its overall organization and financing. Second, it details d

Совпадение в полном тексте источника
… In accordance with European Union Regulations on the coordination of social security systems and cross-border health care, Danish residents have the right to be reimbursed for the costs of health care provided in other European Union/European Economic Area Member States. 5 GPs practice privately and …

An Observational Study of the First 100 Patients Undergoing Nocturnal Every-Other-Day Online Hemodiafiltration: Clinical Outcomes and Patient and Technique Survival.

Background: High-volume online hemodiafiltration (OL-HDF) has proven to be the most efficient dialysis modality and to offer better clinical outcomes in patients on hemodialysis. Longer and more frequent dialysis sessions have demonstrated clinical and survival benefits. Methods: A single-center observational study of the first one hundred patients on nocturnal every-other-day OL-HDF was conducted with the aim of reporting the experience with this treatment schedule and evaluating analytical and clinical outcomes as well as the patient and technique survival. Results: Nocturnal OL-HDF on alter

Work Ability in Patients with Chronic Myeloid Leukemia: A Danish Nationwide Cohort Study.

Background/Objectives: Patients with chronic myeloid leukemia (CML) have a long life expectancy due to modern treatment. However, treatment may have adverse effects that hamper work ability. Methods: Patients aged 25-60 years diagnosed in 2002-2020 were included in this nationwide matched cohort study examining work ability from diagnosis (index date), including the need for permanent disability compensation (flexible job or disability pension). Each patient was matched 1:5 on sex, birth year, and level of comorbidity with citizens from the general Danish population without CML. The risks of r

Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion.

Purpose2021 marks the tenth anniversary of the AMNOG process and brought with it a new German administration-two good reasons to take stock of where we stand today, what has been achieved so far, and how the path of early benefit assessments in Germany should continue.ResultsFrom the perspective of manufacturers of cancer drugs, the AMNOG process, as a constantly evolving system, has for the most part proved itself-which does not mean that there is no longer room for improvement. Significant improvements have been achieved in the area of early consultation of medical societies regarding the se

Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home.

At home injectable chemotherapy for patients receiving treatment for hematological diseases is still in debate. Given the expense of new innovative medicines, at home treatment has been proposed as a suitable option for improving patient quality of life and decreasing treatment costs. We decided to assess the cost of bortezomib administration in France among multiple myeloma patients from an economic standpoint. Patients in this study were treated within a regional hematological network combining outpatient hospital care and Hospital care at Home administration. To make the cost comparison, ou

Совпадение в полном тексте источника
… Order of 28 February 2012 fixing for 2012 the tariff items mentioned in I and IV of Article L. 162-22-10 of the Social Security Code and IV and V of the amended Article 33 of Law social security funding for 2004. http://www.legifrance.gouv.fr/affichTexte.do;jsessionid=3E7798D70773D40F58B9F53F961661F6 …

Navigating family life in the face of parental cancer: a qualitative study.

PurposeParental cancer can significantly impact family dynamics, particularly for adolescents and young adults (AYAs), who face the developmental task of balancing autonomy and connectedness. As cancer incidence rises globally, more AYAs are confronted with the challenges of parental illness. While most research focuses on individual psychological outcomes, less is known about how families function as a unit under such stress. This study aimed to gain deeper insight into family functioning, with a specific focus on autonomy, connectedness, and communication, in the face of parental cancer.Meth

SiMON-PRO-Hematology®: Digital techology for pharmacotherapeutic and patient reported outcomes monitoring in patients with hematologic malignancies.

INTRODUCTION: Advances in hematologic malignancy treatment have improved survival, but patients often experience treatment-related toxicities. Traditional clinical follow-up often overlooks the patient's subjective experience, highlighting the need for integrated patient-reported outcome measures (PROMs). The primary objective of this study was to describe the design and implementation of the SiMON-PRO-Hematology® system, a comprehensive information tool supporting the pharmacotherapeutic follow-up of patients with hematological malignancies. A secondary objective was to detail the process for

Лечение пациентов с гематологическим раком на дому в Дании - национальный обзор.

ЦЕЛЬ: Изучение масштабов и практики лечения на дому пациентов с гематологическими заболеваниями в Дании. МЕТОДЫ: Это общенациональное исследование проводилось во всех датских гематологовых департаментах (n = 9). На каждом сайте был получен онлайновый вопросник для сбора данных о типе терапии, применяемой в качестве лечения на дому, о конкретных методах лечения с подробной информацией о целевых группах населения, критериях для пациентов, ходе осуществления и практике клинического лечения.Результаты: Six В датских гематологических отделениях в качестве домашнего лечения предлагались такие виды т

Совпадение в полном тексте источника
… In Denmark, the basic principle of the welfare system is that most healthcare services are tax-funded and provided free of charge, ensuring all residents have equal access and rights to social security and healthcare benefits The treatment for hematologic malignancies is centralized at five university …

Virtual music therapy during the COVID-19 pandemic: an updated scoping review.

ObjectiveThe objective of this update to a previously published scoping review was to map how music therapists used virtual music therapy during the COVID-19 pandemic.IntroductionVirtual music therapy underwent significant development during the COVID-19 pandemic. Consequently, the number of publications increased dramatically compared to early 2021, when only 10 records were available. An update to the previous scoping review was necessary to explore the current state of this emerging music therapy discipline and provide important information for health care practitioners, scholars, and resea

Исследование показало, что дисфункция тазового пола у женщин с множественным склерозом является неудовлетворенной потребностью в уходе за больными.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Оценка степени усталости пациента при множественном склерозе с использованием финского регистра MS.

ЦЕЛИ: Охарактеризовать усталость пациента с помощью финских данных о множественном склерозе (MS). МАТЕРИАЛЫ И МЕТОДЫ: Усталость оценивалась по шкале утомления (FSS), шкале утомления моторных и когнитивных функций (FSMC) и шкале Визуального аналога (Visual Analogue). Острота заболеваний оценивалась с помощью расширенной шкалы инвалидности и симптомов с помощью шкалы Визуального Аналога. К числу результатов, о которых сообщили пациенты (ПРО), относятся неевропсихологический вопросник по множественным склерозам, Евро Качество жизни - 5 измерений, 15 D и шкала воздействия множественных склерозов.

Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.

Patients experiencing financial distress as a side-effect of cancer are not only reported in the United States, but also in third-party payer healthcare systems in Europe. Since validated survey instruments are a prerequisite for robust and comparable results, we aimed to compile and classify available instruments to enable both a better understanding of the underlying construct of financial toxicity and to facilitate further studies that are adjustable to various healthcare systems. We did a systematic literature search on studies that provide data on perceived cancer-related financial distre

Совпадение в полном тексте источника
… While in the United States, due to a lack of general security systems, private assets must compensate the loss of income in most cases, in European social security systems other compensation benefits such as sick pay or reduced pension payments through early retirement play a major role. …

Navigating Hope and Illness Cognition in Advanced Ovarian Cancer Patients: A CSM-Based Phenomenological Study.

BACKGROUND: Advanced ovarian cancer patients face profound psychosocial challenges in maintaining hope amidst terminal illness and treatment uncertainty. Understanding mechanisms supporting adaptive hope could inform psychosocial interventions. METHODS: Phenomenological qualitative study of 16 women with advanced ovarian cancer receiving platinum-based and/or targeted therapies at a tertiary center in southern China. Semi-structured interviews conducted across 11-month observation period; thematic analysis guided by Leventhal's Common-Sense Model (CSM). RESULTS: Participants demonstrated a t

Overcoming obstacles to repurposing for neurodegenerative disease.

Repurposing Food and Drug Administration (FDA)-approved drugs for a new indication may offer an accelerated pathway for new treatments to patients but is also fraught with significant commercial, regulatory, and reimbursement challenges. The Alzheimer's Drug Discovery Foundation (ADDF) and the Michael J. Fox Foundation for Parkinson's Research (MJFF) convened an advisory panel in October 2013 to understand stakeholder perspectives related to repurposing FDA-approved drugs for neurodegenerative diseases. Here, we present opportunities on how philanthropy, industry, and government can begin to a

The Association Between Social Support and Psychosomatic Status in Cancer Patients During Mid-Course Radiotherapy: The Chain Mediating Roles of Psychological Capital and Coping Styles.

Background: Cancer patients undergoing mid-course radiotherapy frequently experience psychosomatic distress, yet the psychosocial correlates and indirect pathways associated with this phenomenon remain insufficiently understood. Objective: To examine the direct and indirect associations between social support and psychosomatic status through psychological capital and coping styles in cancer patients undergoing mid-course radiotherapy. Methods: A cross-sectional study was conducted among 327 cancer patients recruited from the radiotherapy center of a tertiary-level general hospital between Augu

Experiences of Multiple Myeloma Patients With Treatment in the Palestinian Practice: A Multicenter Qualitative Study in a Resource-Limited Healthcare System.

Background Multiple myeloma is a crippling cancer that puts a significant strain on patients and their families alike. The long and exhausting treatment journey with the disease is challenging not only for patients but also for healthcare systems. This exploratory study was conducted to look into these patients' experiences with their treatment and explore their recommendations and views to improve the Palestinian healthcare system, which can be viewed as an evolving healthcare system within a resource-limited and developing country. Methods The consolidated criteria for reporting qualitative

The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey.

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening disease with symptoms of hemolysis and thrombosis. Current therapies for this complement-mediated disease rely predominantly on inhibition of the C5 complement protein. However, data on treatment responses and quality of life in C5-inhibitor (C5i)-treated PNH patients are scarce. The objective of this study was to determine C5i treatment effects on clinical parameters, PNH symptoms, quality of life, and resource use for PNH patients. This cross-sectional study surveyed 122 individuals in the USA receiving treatment for PN

Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administration.

Adoptive cellular therapy has made a landmark change within the treatment paradigm of several hematologic malignancies, and novel cellular therapy products, such as chimeric antigen receptor T-cell therapy (CART), have demonstrated impressive efficacy and produced durable responses. However, the CART treatment process is associated with significant toxicities, healthcare resource utilization, and financial burden. Most of these therapies have been administered in the inpatient setting due to their toxicity profile. Improved toxicity management strategies and a better understanding of cellular

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study.

BackgroundPatients with cancer often face significant financial challenges, known as financial toxicity (FT), which is associated with reduced quality of life. Patients with hematologic malignancies (HMs) are especially vulnerable due to intensive and prolonged treatments, frequent hospital visits, and a high risk of complications. While FT affects many in the general population, it is particularly severe among racial and ethnic minorities, especially those below the poverty line. To our knowledge, no studies have specifically examined FT in this vulnerable group in the United States.Objective